JAZZ vs MRNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 25, 2026

JAZZ

59.6
AI Score
VS
MRNA Wins

MRNA

60.1
AI Score

Investment Advisor Scores

JAZZ

60score
Recommendation
HOLD

MRNA

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric JAZZ MRNA Winner
Forward P/E 12.3305 23.0415 JAZZ
PEG Ratio 0.9411 0 Tie
Revenue Growth 19.1% 260.2% MRNA
Earnings Growth 3.2% -85.1% JAZZ
Tradestie Score 59.6/100 60.1/100 MRNA
Profit Margin 0.7% -143.6% JAZZ
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY MRNA

Frequently Asked Questions

Based on our detailed analysis, MRNA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.